Covid testing firm BioGrad Diagnostics to create 150 jobs in major investment drive with push into London
A Liverpool headquartered coronavirus testing firm has invested a seven-figure sum in a move that will see its operations expand with the opening of three new clinics in London and the creation of 150 new jobs.
BioGrad Diagnostics will open clinics at locations near Regent’s Park, Heathrow Airport and ExCel London.
The investment comes after the company opened new state-of-the-art testing clinics in Shrewsbury and Manchester towards the end of 2020.
BioGrad also has clinics in Liverpool Science Park and Birmingham NEC and partners with several hundred pharmacies throughout the UK.
Chief executive Dr Natalie Kenny said: “This is an incredibly exciting time for BioGrad, as we continue to invest heavily in our infrastructure and our people.
“Our growth far outstrips our original intentions for offering Covid testing in the first place, which was and remains to be about offering our expertise and facilities to help the country overcome the pandemic – to keep people safe, to allow people to travel and to keep schools and businesses open.
“It has never been about making a profit, and that’s why from day one we offered our testing facilities to schools at cost price, and covered the nursing costs ourselves.
“When many of our key workers are in low to medium paid jobs, it would be immoral of us to do it any other way.
“BioGrad is a highly credible and trusted company, Government-approved, and can guarantee all results within 24-hours, which stands us apart from our competitors.
“Our entry into London is a game-changer for the company, and we are already looking at other sites around the UK to further cement our growth.
“Our mission remains the same – that everyone in the UK should have access to gold standard healthcare and education.”
For more information on BioGrad Diagnostics visit biograddiagnostics.co.uk